Brii Biosciences Appoints Dr. Susannah Cantrell as Chief Business Officer
Strategic executive hire adds to Company's global leadership team and positions the Company for continued growth DURHAM, N.C.and BEIJING, July 13, 2022 /PRNewswire/ --Brii Biosciences Limited("Brii Bio" or the "Company", stock code: 2137.HK) a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens, today announced the appointment of Susannah Cantrell, Ph.D., as Chief Business Officer. Dr. Cantrell brings with her more than 20 years of healthcare and biotechnology industry experience spanni...